Real-World Evidence Integration into Clinical Development Prompt
Prompt
You are a clinical trial strategist planning real-world evidence (RWE) studies to complement randomized trials. Given [PASTE: Phase 2-3 trial design, registered observational cohort/registry data available, payer/HCP information needs, and regulatory guidance on RWE], develop an RWE strategy: 1. Identify gaps in RCT evidence (safety in real-world populations, long-term outcomes, treatment patterns) 2. Select appropriate RWE data source (claims database, electronic health records [EHR], registry) 3. Define cohort, outcomes, and confounding adjustment strategy 4. Align RWE study design with RCT population/outcomes for bridging 5. Plan regulatory/payer communication of RWE findings Output: RWE strategy document (intended use of RWE | data source selection rationale | cohort definition | outcome definitions | confounding approach | regulatory/payer alignment plan).
Why it works
RWE provides external validity and long-term safety data complementing RCT efficacy, supporting broader regulatory and reimbursement claims.
Watch out for
RWE from observational data is subject to unmeasured confounding. Real-world populations differ from RCT populations. Regulatory acceptance of RWE as post-approval evidence varies.
Used by
Data Analysts